H. Mizusawa et al., Morphological and functional in vitro and in vivo characterization of the mouse corpus cavernosum, BR J PHARM, 132(6), 2001, pp. 1333-1341
1 In normal mice, the distribution of adrenergic, cholinergic, some peptide
rgic, and neuronal nitric oxide synthase (nNOS)-containing nerves were inve
stigated. Functional in vitro correlates were obtained. An in viva model wa
s developed in which erectile haemodynamics in response to drugs or nerve-s
timulation were studied.
2 Immunoreactivities for vesicular acetylcholine transporter protein (VAChT
), nNOS-, and vasoactive intestinal polypeptide (VIP), co-existed in nerve
fibres and terminal varicosities. Immunoreactivities for neuropeptide Y (NP
Y) and tyrosine hydroxylase (TH) were found in the same nerve structures.
3 Chemical sympathectomy abolished TH- and NPY-IR nerve structures in caver
nous smooth muscle bundles. The distribution of calcitonin gene-related pep
tide (CGRP)-, nNOS-, VAChT- and VIP-IR nerve structures was unchanged.
4 In endothelial cells of the central and helicine arteries, veins and venu
les, intense immunoreactivity for endothelial NOS (eNOS) was observed. No d
istinct eNOS-IR cells were found lining the cavernous sinusoids.
5 in vitro, nerve-induced relaxations were verified, and endothelial NO/cyc
lic GMP-mediated relaxant responses were established. VIP and CGRP had smal
l relaxant effects. A functioning adenylate cyclase/cyclic AMP pathway was
confirmed.
6 Neuronal excitatory responses were abolished by prazosin, or forskolin. V
IP and CGRP counteracted contractions, whereas NPY and scopolamine enhanced
excitatory responses.
7 In vivo, erectile responses were significantly attenuated by L-NAME (50 m
g kg(-1)) and facilitated by sildenafil (200 mug kg(-1)).
8 It is concluded that the mouse is a suitable model for studies of erectil
e mechanisms in vitro and in vivo.